sacituzumab
gilead sciences
['mbc', ' sg ', 'sacituzumab', 'sacitu, govi', 'tropics-02']
#esmo2022 tropics-02: sacituzumab govitecan (sg) demonstrated statistically significant and clinically meaningful improvement in os vs tpc, supporting the use of sg as a novel therapy for pts with pre-treated hr+/her2- mbc. #adc #positiveresults 